6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Details for Australian Patent Application No. 2004266160 (hide)

Owner Ligand Pharmaceuticals Incorporated

Inventors Long, Yun Oliver; Martinborough, Esther; Shen, Yixing; Wu, Min; Zhi, Lin; Stevens Lau, Thomas Lot

Agent Spruson & Ferguson

Pub. Number AU-A-2004266160

PCT Pub. Number WO2005/018573

Priority 60/497,125 22.08.03 US

Filing date 23 August 2004

Wipo publication date 3 March 2005

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 215/12 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/16 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/018573 Priority application(s): WO2005/018573

18 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266161-Device and method for intradermal cell implantation

2004266159-Improved antibodies having altered effector function and methods for making the same